HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

proinsulin-like growth factor II

abnormal processing of pro-IGF-II takes place in patients with hepatoma & in some hepatitis B virus antibody-positive asymptomatic individuals
Also Known As:
big insulin-like growth factor II; pro-IGF-II
Networked: 29 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. van Doorn, Jaap: 3 articles (05/2015 - 10/2002)
2. Rikhof, Bart: 2 articles (07/2012 - 03/2009)
3. Meijer, Coby: 2 articles (07/2012 - 03/2009)
4. van der Graaf, Winette T A: 2 articles (07/2012 - 03/2009)
5. Suurmeijer, Albert J H: 2 articles (07/2012 - 03/2009)
6. de Jong, Steven: 2 articles (07/2012 - 03/2009)
7. Frystyk, Jan: 2 articles (05/2010 - 12/2005)
8. Flyvbjerg, Allan: 2 articles (05/2010 - 12/2005)
9. Espelund, Ulrick: 2 articles (05/2010 - 12/2005)
10. Le Bouc, Yves: 2 articles (07/2008 - 03/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Obesity
3. Hypoglycemia (Reactive Hypoglycemia)
4. Hepatocellular Carcinoma (Hepatoma)
5. Infection

Related Drugs and Biologics

1. Insulin-Like Growth Factor II (Somatomedin A)
2. Insulin-Like Growth Factor I (IGF-1)
3. Peptides
4. Insulin (Novolin)
5. Antibodies
6. Biological Markers (Surrogate Marker)
7. RNA (Ribonucleic Acid)
8. Prothrombin (Factor II)
9. Hormones
10. MASS syndrome

Related Therapies and Procedures

1. Caloric Restriction